Tilvalosin (as tartrate) 20.00 mg, Chlortetracycline (as hydrochloride) 200.00 mg, Excipients 1.00 g.

For the treatment and prevention of digestive and respiratory diseases caused by microorganisms sensitive to tylvalosin and chlortetracycline, mainly mycoplasmosis respiratory disease in poultry, swine enzootic pneumonia, swine dysentery and ileitis. The addition of chlortetracycline increases the effect of the antibiotic, enhancing its action and expanding its range to mixed infections with Gram negative microorganisms.

Tylvalosin is a new macrolide antibiotic with high efficiency, up to 10 times the tylvalosin resulting of this a superior antimycoplasmal efficacy. Tilvax C Px provides faster absorption, better bioidisponibilidad and higher concentrations in blood than those achieved with the tylvalosin, ensuring a wide distribution to specific areas and pulmonary airway blood. Chlortetracycline belongs to the group of tetracyclines and acts bacteriostatic against many Gram positive and negative bacteria.